ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+3.73%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$290M
AUM Growth
+$290M
(+18%)
Cap. Flow
+$37.8M
Cap. Flow
% of AUM
13.06%
Top 10 Holdings %
Top 10 Hldgs %
50.21%
Holding
82
New
24
Increased
19
Reduced
13
Closed
21
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$21.3M |
| 2 |
Integra LifeSciences
IART
|
$13.3M |
| 3 |
AbbVie
ABBV
|
$11.9M |
| 4 |
AdaptHealth
AHCO
|
$9.76M |
| 5 |
Encompass Health
EHC
|
$8.77M |
Top Sells
| 1 |
Medtronic
MDT
|
$6.95M |
| 2 |
SI-BONE Inc
SIBN
|
$6.65M |
| 3 |
ICU Medical
ICUI
|
$6.55M |
| 4 |
Labcorp
LH
|
$6.3M |
| 5 |
Centene
CNC
|
$5.58M |
Sector Composition
| 1 | Healthcare | 97.22% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Bristol-Myers Squibb
BMY
$96B
| $23.5M | 6.96% | 390,156 +354,047 | +980% | +$21.3M |
|
|
OXFD
2
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $20.5M | 6.07% | 1,754,465 +357,670 | +26% | +$4.18M |
|
|
3
Encompass Health
EHC
$12.3B
| $17.9M | 5.31% | 276,105 +134,910 | +96% | +$8.77M |
|
|
4
AbbVie
ABBV
$372B
| $17.4M | 5.15% | 198,921 +136,306 | +218% | +$11.9M |
|
|
5
Integra LifeSciences
IART
$1.18B
| $13.3M | 3.93% | +281,608 | New | +$13.3M |
|
6
Cigna
CI
$80.3B
| $11.4M | 3.38% | 67,461 +31,339 | +87% | +$5.31M |
|
|
7
AdaptHealth
AHCO
$1.28B
| $11.3M | 3.34% | 518,377 +447,377 | +630% | +$9.76M |
|
8
Johnson & Johnson
JNJ
$427B
| $11.2M | 3.3% | 74,979 -8,900 | -11% | -$1.33M |
|
|
9
SI-BONE Inc
SIBN
$719M
| $11M | 3.25% | 463,150 -280,230 | -38% | -$6.65M |
|
10
Zoetis
ZTS
$69.3B
| $7.77M | 2.3% | 46,960 -26,240 | -36% | -$4.34M |
|
11
Zimmer Biomet
ZBH
$21B
| $7.38M | 2.18% | 54,234 +8,196 | +18% | +$1.12M |
|
12
CONMED
CNMD
$1.68B
| $6.39M | 1.89% | +81,205 | New | +$6.39M |
|
13
Ocular Therapeutix
OCUL
$2.12B
| $6.37M | 1.88% | 837,137 +81,807 | +11% | +$623K |
|
14
McKesson
MCK
$85.4B
| $6.02M | 1.78% | 40,419 +24,477 | +154% | +$3.65M |
|
|
SYNH
15
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $5.96M | 1.76% | 112,151 +57,574 | +105% | +$3.06M |
|
16
OrthoPediatrics
KIDS
$536M
| $5.82M | 1.72% | +126,764 | New | +$5.82M |
|
|
TRIL
17
DELISTED
Trillium Therapeutics Inc.
TRIL
| $5.29M | 1.57% | 372,401 -305,422 | -45% | -$4.34M |
|
18
Esperion Therapeutics
ESPR
$448M
| $5.05M | 1.49% | 135,901 -47,348 | -26% | -$1.76M |
|
19
Elevance Health
ELV
$71.8B
| $4.81M | 1.42% | 17,909 -12,119 | -40% | -$3.25M |
|
20
Sutro Biopharma
STRO
$72.7M
| $4.65M | 1.37% | 462,170 +306,165 | +196% | +$3.08M |
|
21
Insmed
INSM
$28.8B
| $4.64M | 1.37% | 144,313 +4,129 | +3% | +$133K |
|
|
MTEM
22
DELISTED
Molecular Templates, Inc.
MTEM
| $4.62M | 1.37% | 422,787 +192,970 | +84% | +$2.11M |
|
|
ADAP
23
Adaptimmune Therapeutics
ADAP
$15.6M
| $4.59M | 1.36% | 574,502 +91,399 | +19% | +$729K |
|
24
Mustang Bio
MBIO
$10.9M
| $4.48M | 1.33% | 1,423,050 +654,579 | +85% | +$2.06M |
|
|
25
Centene
CNC
$14.3B
| $4.34M | 1.28% | 74,408 -95,649 | -56% | -$5.58M |
|